| Patents for A61P 17 - Drugs for dermatological disorders (106,455) |
|---|
| 09/18/2003 | WO2003076416A1 Oxo azabicyclic compounds |
| 09/18/2003 | WO2003076407A1 Novel chalcone derivatives and uses thereof |
| 09/18/2003 | WO2003076401A1 Sulfonylamino-derivatives as novel inhibitors of histone deacetylase |
| 09/18/2003 | WO2003076400A1 New inhibitors of histone deacetylase |
| 09/18/2003 | WO2003076399A1 Compounds capable of inhibiting immunocyte-related allergic immune reactions |
| 09/18/2003 | WO2003076393A1 Salts of nateglinide |
| 09/18/2003 | WO2003075953A2 Immunomodulatory polymeric antigens for treating inflammatory pathogies |
| 09/18/2003 | WO2003075935A1 Drugs containing riboflavin-type compounds |
| 09/18/2003 | WO2003075932A1 1-alpha-hydroxy-2-methylene-19-nor-pregnacalciferol and its uses |
| 09/18/2003 | WO2003075929A1 Inhibitors of histone deacetylase |
| 09/18/2003 | WO2003075913A1 Topical compostions comprising furfuryl derivatives and their use for the treatment of dermatologic disorders |
| 09/18/2003 | WO2003075908A1 Use of adapalene for the treatment of dermatological disorders |
| 09/18/2003 | WO2003075901A2 Use of s-substituted l-crysteine for the manufacture of a medicament for the treatment of dermatological disorders |
| 09/18/2003 | WO2003075900A2 Utilization of ubiquinones for influencing the effect of histamine |
| 09/18/2003 | WO2003075891A1 Dispersed solid-containing complex carbohydrate |
| 09/18/2003 | WO2003075876A1 New composition including a pigment assembly comprising a mica core |
| 09/18/2003 | WO2003075857A2 Amino-methyl substituted tetracycline compounds |
| 09/18/2003 | WO2003075847A2 NOVEL CURCUMINOID-FACTOR VIIa CONSTRUCTS AS SUPPRESSORS OF TUMOR GROWTH AND ANGIOGENESIS |
| 09/18/2003 | WO2003075834A2 Activated protein c formulations |
| 09/18/2003 | WO2003075812A1 Controlled delivery patch of active ingredient |
| 09/18/2003 | WO2003075741A2 METHODS OF PREVENTING OR TREATING DISORDERS BY ADMINISTERING AN INTEGRIN αvβ3 ANTAGONIST IN COMBINATION WITH AN HMG-CoA REDUCTASE INHIBITOR OR A BISPHOSPHONATE |
| 09/18/2003 | WO2003075670A1 Treatment and prevention of inflammatory disorders |
| 09/18/2003 | WO2003059296A3 Compositions comprising collagen and metalloprotease inhibitors |
| 09/18/2003 | WO2003059283A3 Compounds for blocking androgen receptors |
| 09/18/2003 | WO2003053915A3 Compounds for the treatment of inflammatory disorders |
| 09/18/2003 | WO2003053368A3 Chalcone derivatives and their use to treat diseases |
| 09/18/2003 | WO2003051893A3 Improvements in pharmaceutical compositions |
| 09/18/2003 | WO2003051807A3 Improvements in pharmaceutical compositions |
| 09/18/2003 | WO2003045349A3 Itch-relieving cosmetic and dermatological preparations |
| 09/18/2003 | WO2003037308A3 Utilization of inhibitors of rho-kinases for stimulating nerve growth, inhibiting scar tissue formation and/or reducing a secondary lesion |
| 09/18/2003 | WO2003035007A3 Curcuminoid compositions exhibiting synergistic inhibition of the expression and/or activity of cyclooxygenase-2 |
| 09/18/2003 | WO2003005980A3 Cosmetic and dermatological preparations containing carnitine |
| 09/18/2003 | WO2002102411A3 Method for treating psoriasis by using an il-17d antagonist |
| 09/18/2003 | WO2002083700B1 Hypersulfated disaccharides and methods of using the same for the treatment of inflammations |
| 09/18/2003 | WO2002077174A3 Human cytokine receptor |
| 09/18/2003 | WO2002066646A3 Neurotransmission-associated proteins |
| 09/18/2003 | WO2002062750A9 Cannabinoid receptor ligands |
| 09/18/2003 | WO2002059308A3 Method of diagnosing and treating cartilage disorders |
| 09/18/2003 | US20030176726 Selective retinoid agonists |
| 09/18/2003 | US20030176686 Diagnosis, therapy; animal growth regulators; controlling cell differentiation; antiiinflammatory agents, antihistamines, Crohn's disease, anticancer agents, autoimmune disease |
| 09/18/2003 | US20030176642 Peptoid and nonpeptoid containing alpha-keto oxadiazoles as serine protease inhibitors |
| 09/18/2003 | US20030176509 Methods and products related to 16-HETE analogs |
| 09/18/2003 | US20030176497 Carboxamide-substituted phenylurea derivatives, process for their preparation and their use as medicaments |
| 09/18/2003 | US20030176496 Administering an antiproliferative agent in combination with a potentiating effective amount of a N- substituted dithiocarbamate ester or a pharmaceutically acceptable salt thereof |
| 09/18/2003 | US20030176491 For therapy and prophylaxis of prostatitis or interstitial cystitis, inflammatory bowel disease, Crohn's disease, ulcerative proctitis, or colitis, prostatic hypertrophy, uterine leiomyomas, breast cancer, endometrial cancer |
| 09/18/2003 | US20030176487 For therapy and prophylaxis of disorders related to unregulated tyrosine kinase signal transduction, including cell proliferative and metabolic disorders |
| 09/18/2003 | US20030176470 For prophylaxis and/or therapy of skin diseases and/ or inflammation responses of the skin |
| 09/18/2003 | US20030176463 For therapy of disease states resulting from angiogenesis; can be administered orally |
| 09/18/2003 | US20030176455 Inhibiting cell death following cellular regeneration in a mammal in need thereof, which comprises providing with an effective amount of a rapamycin |
| 09/18/2003 | US20030176453 Compositions and formulations of 9-nitrocamptothecin polymorphs and methods of use therefor |
| 09/18/2003 | US20030176451 Reacting a heterocyclic-methanesulfonyl substituted-quinazolineamine compound with amine compound |
| 09/18/2003 | US20030176445 Substituted 1,4-dihydropyridine compounds as bradykinin antagonists |
| 09/18/2003 | US20030176442 Administering cGMP PDE5 inhibitor for therapy of diabetic ulcers |
| 09/18/2003 | US20030176430 For therapy and prophylaxis of Tachykinin-mediated diseases |
| 09/18/2003 | US20030176425 Novel 1,2,4-thiadiazole derivatives as melanocortin receptor modulators |
| 09/18/2003 | US20030176422 Pyridoarylphenyl oxazolidinone antibacterials, and related compositions and methods |
| 09/18/2003 | US20030176420 Treatment of T-helper cell type 2-mediated immune diseases by retinoid antagonists |
| 09/18/2003 | US20030176419 As inhibitors of the retinoic acid-metabolism, as drugs |
| 09/18/2003 | US20030176417 Reversing advanced glycosylation cross-links using heterocyclic-substituted thiazolium compounds |
| 09/18/2003 | US20030176416 For therapy of disease, disorder or condition is responsive to modulation of cholinergic receptors and/or monoamine receptors |
| 09/18/2003 | US20030176411 Photodynamic therapy for pre-melanomas |
| 09/18/2003 | US20030176408 For topical application, penetration |
| 09/18/2003 | US20030176379 Useful in the administration of a drug, therapy |
| 09/18/2003 | US20030176366 Topical application of ascorbic acid compounds for augmenting the synthesis of epidermal ceramides |
| 09/18/2003 | US20030176363 For therapy of T lymphocyte mediated inflammatory diseases in animals and man |
| 09/18/2003 | US20030176349 Stable hypoxia inducible factor-1 alpha and method of use |
| 09/18/2003 | US20030176331 Having therapeutic, diagnostic, and preventative benefits, particularly as immunotoxins; for therapy of cancer |
| 09/18/2003 | US20030176318 Administering a therapeutically effective amount of a temporary p53 inhibitor to an individual suffering from the disease or condition |
| 09/18/2003 | US20030176317 Stabilization of hypoxia inducible factor (HIF) alpha |
| 09/18/2003 | US20030176315 Contacting latency-associated peptide- beta 1 (LAP- beta 1) or a functional variant thereof and integrin alpha v beta 3 or a functional variant thereof with test product under conditions that, in absence of test product, would permit interaction |
| 09/18/2003 | US20030176303 Novel detergent compositions with enhanced depositing, conditioning and softness capabilities |
| 09/18/2003 | US20030175962 Gene encoding b protein |
| 09/18/2003 | US20030175934 Controlling cell differentiation, cell proliferation; anticancer agents |
| 09/18/2003 | US20030175920 Cell-permeable peptide inhibitors of the JNK signal transduction pathway |
| 09/18/2003 | US20030175885 Peptides and derivatives thereof showing cell attachment, spreading and detachment activity |
| 09/18/2003 | US20030175881 Nucleic acids encoding (poly) peptides having chips activity |
| 09/18/2003 | US20030175805 Comprises winglesslint 8D (Wnt-8D) polypeptides for treating asthma, nervous system, psychological, alzheimer, cancer, cardiomyopathies, lung and kidney disorders; wound healing agents; tissue engineering |
| 09/18/2003 | US20030175374 Oxidation resistance; anticancer agents, antiinflammatory agents; sunscreen agents |
| 09/18/2003 | US20030175370 Dry mixture of carbohydrates and drugs; wound healing agents |
| 09/18/2003 | US20030175366 Plant Extracts and Methods of Treating Skin Therewith |
| 09/18/2003 | US20030175334 Phospholipid bodies and use thereof in medical treatment |
| 09/18/2003 | US20030175333 Invisible patch for the controlled delivery of cosmetic, dermatological, and pharmaceutical active ingredients onto the skin |
| 09/18/2003 | US20030175331 Pressure sensitive adhesive comprising isoprene-styrene block copolymer/tackifier resin and diclofenac sodium |
| 09/18/2003 | US20030175328 Patch for the controlled delivery of cosmetic, dermatological, and pharmaceutical active ingredients into the skin |
| 09/18/2003 | US20030175315 Nanoemulsion comprising metabolites of ginseng saponin as an active component and a method for preparing the same, and a skin-care composition for anti-aging containing the same |
| 09/18/2003 | US20030175314 Pharmaceutical composition for dermal application |
| 09/18/2003 | US20030175289 TIE ligands |
| 09/18/2003 | US20030175280 Antagonists to chaperonin 10 |
| 09/18/2003 | US20030175274 Polynucleotides codes for antibodies having amino acid sequences selected from complementary determining regions of variable peptides or single chain fragments, used as anticarcinogenic agents |
| 09/18/2003 | US20030175269 Light and heavy chain peptides, used as antagonists of CD antigen or membrane proteins, for prophylaxis of autoimmune diseases |
| 09/18/2003 | US20030175258 Mixing shoots of Pinaceae plants with water and saccharides followed by spontaneous fermenting with yeasts to form remedies for allergic diseases; side effect reduction; for treatment of asthma, atopic dermatitis |
| 09/18/2003 | US20030175256 Allografts comprising undifferentiated fetal skin cells integrated within collagen matrix |
| 09/18/2003 | US20030175248 Comprises thrombocyte-rich plasm and calcium phosphates for use in skin and bone defects |
| 09/18/2003 | US20030175205 Comprising a radioactive materials for detecting and/or quantifying diseases or conditions associated with cancer, infections, inflammation; a 2-propane carboxylic ester with a attached phosphatidic acid group |
| 09/18/2003 | DE20311290U1 Cosmetics containing e.g. wool fat, milk fat, rum, honey, red wine, gelatin, camomile extract, glycerol, peppermint extract and lemon extract are active against variety of ailments |
| 09/18/2003 | DE20307237U1 Mixtures and tinctures containing calcium carbonate and sulfur optionally also contain arsenic and are useful in hair removal or pest control or as disinfectants |
| 09/18/2003 | CA2478996A1 New composition including a pigment assembly comprising a mica core |
| 09/18/2003 | CA2478942A1 An optically active pyridine derivative and a medicament containing the same |
| 09/18/2003 | CA2478921A1 Novel chalcone derivatives and uses thereof |
| 09/18/2003 | CA2478897A1 Compounds capable of inhibiting immunocyte-related allergic immune reactions |